Background/Aims: The decreasing incidence of chronic rejection after l
iver transplantation emphasizes the need for an alternative end-point
to assess the long-term consequences of acute rejection. The purpose o
f this study was to determine the effects of resolved episodes of acut
e rejection on late liver allograft function. Methods: Parameters of h
epatic function (liver biochemistry, indocyanine green and sulfobromop
hthalein clearances, histology) were analyzed in 170 consecutive adult
recipients, who were followed prospectively on the basis of repeat an
nual work-up. Mean follow-up was 3.7+/-0.2 years. Results: The rates o
f acute and chronic rejection were 51% and 4.1%, respectively. At the
last follow-up, there was no significant difference in graft function
between patients with a single episode of acute rejection (n=56) and t
hose without rejection (n=84). Among patients treated for a single epi
sode of acute rejection, late hepatic function was not influenced by t
he severity of acute rejection and the response to corticosteroids, In
contrast, patients with recurrent acute rejection (n=30) had signific
ant impairment of liver function tests (aspartate aminotransferase, p<
0.05; alanine aminotransferase, p<0.01; alkaline phosphatase, p<0.01;
gamma-glutamyl transpeptidase, p<0.001), lower dye clearances (indocya
nine green, p<0.01; sulfohromophthalein, p<0.01) and more severe histo
logic damage (p<0.001). Conclusions: Single episodes of acute rejectio
n do not impair the long-term hepatic function, whereas recurrent epis
odes leave sequellar damage to the liver allograft. These results prov
ide a rationale for converting patients with rejection to a heavier im
munosuppressive regimen, while leaving nearly half the recipients on a
lifelong light immunosuppressive regimen.